Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds (2016)

  • Authors:
  • USP affiliated authors: SANNOMIYA, MIRIAM - EACH
  • USP Schools: EACH
  • DOI: 10.1007/s10616-016-9998-6
  • Subjects: ANTIOXIDANTES; CITOMETRIA DE FLUXO; FITOTERAPIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s10616-016-9998-6 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: green
    Versões disponíveis em Acesso Aberto do: 10.1007/s10616-016-9998-6 (Fonte: Unpaywall API)

    Título do periódico: Cytotechnology

    ISSN: 0920-9069,1573-0778

    • Melhor URL em Acesso Aberto:
      • Página do artigo
      • Link para o PDF
      • Evidência: oa repository (via OAI-PMH title and first author match)
      • Licença:
      • Versão: publishedVersion
      • Tipo de hospedagem: repository


    • Outras alternativas de URLs em Acesso Aberto:
        • Página do artigo
        • Link para o PDF
        • Evidência: oa repository (via OAI-PMH title and first author match)
        • Licença:
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


    Informações sobre o Citescore
  • Título: Cytotechnology

    ISSN: 0920-9069

    Citescore - 2017: 1.46

    SJR - 2017: 0.519

    SNIP - 2017: 0.601


  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SPECIAN, Ana Flávia Leal; SERPELONI, Juliana Mara; TUTTIS, Katiuska; et al. LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds. Cytotechnology : International Journal of Cell Culture and Biotechnology, Dordrecht, n. ju 2016, p. on-line, 2016. Disponível em: < http://dx.doi.org/10.1007/s10616-016-9998-6 > DOI: 10.1007/s10616-016-9998-6.
    • APA

      Specian, A. F. L., Serpeloni, J. M., Tuttis, K., Ribeiro, D. L., Cilião, H. L., Varanda, E. A., et al. (2016). LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds. Cytotechnology : International Journal of Cell Culture and Biotechnology, ( ju 2016), on-line. doi:10.1007/s10616-016-9998-6
    • NLM

      Specian AFL, Serpeloni JM, Tuttis K, Ribeiro DL, Cilião HL, Varanda EA, Sannomiya M, Martínez-López W, Vilegas W, Colus IM de S. LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds [Internet]. Cytotechnology : International Journal of Cell Culture and Biotechnology. 2016 ;( ju 2016): on-line.Available from: http://dx.doi.org/10.1007/s10616-016-9998-6
    • Vancouver

      Specian AFL, Serpeloni JM, Tuttis K, Ribeiro DL, Cilião HL, Varanda EA, Sannomiya M, Martínez-López W, Vilegas W, Colus IM de S. LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds [Internet]. Cytotechnology : International Journal of Cell Culture and Biotechnology. 2016 ;( ju 2016): on-line.Available from: http://dx.doi.org/10.1007/s10616-016-9998-6

    Referências citadas na obra
    Abdullah AH, Mohammed AS, AbdullaH R, Mirghani MES, Al-Qubaisi M (2014) Cytotoxic effects of Mangifera indica L. kernel extract on human breast cancer (MCF-7 andMDA-MB-231 cell lines) and bioactive constituents in the crude extract. J Altern Complement Med 14:1–10. doi: 10.1186/1472-6882-14-199
    Bernhard D, Schwaiger W, Crazzolara R, Tinhofer I, Kofler R, Csordas A (2003) Enhanced MTT—reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells. Cancer Lett 195:193–199. doi: 10.1016/S0304-3835(03)00157-5
    BRASIL (2006) Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos Departamento de Assistência Farmacêutica. Política nacional de plantas medicinais e fitoterápicos, Brasília: Ministério da Saúde, 1–60
    Cecilio AB, De Faria DB, Oliveira PC, Caldas S, De Oliveira DA, Sobral MEG, Duarte MGR, Moreira CPS, Silva CG, De Almeida VL (2012) Screening of Brazilian medicinal plants for antiviral activity against rotavirus. J Ethnopharmacol 141:975–981. doi: 10.1016/j.jep.2012.03.031
    Cilião HL, Ribeiro DL, Camargo-Godoy RB, Specian AF, Serpeloni JM, Cólus IM (2015) Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cells. Exp Toxicol Pathol 67:179–187. doi: 10.1016/j.etp.2014.11.008
    Da Costa Lopes LC, Albano F, Laranja GAT, Alves LM, Silva LFM, Souza GP, Araujo IM, Nogueira-Neto JN, Felzenszwakb I, Kovary K (2000) Toxicological evaluation by in vitro and in vivo assays of an aqueous extract prepared from Echinodorus macrophyllus leaves. Toxicol Lett 116:189–198. doi: 10.1016/S0378-4274(00)00220-4
    Dhawan A, Kayani MA, Parry JM, Parry E, Anderson D (2003) Aneugenic and clastogenic effects of doxorubicin in human lymphocytes. Mutagenesis 18:487–490. doi: 10.1093/mutage/geg024
    Di Giorgio C, Benchabane Y, Boyer G, Piccerelle P, De Méo M (2011) Evaluation of the mutagenic/clastogenic potential of 3, 6-di-substituted acridines targeted for anticancer chemotherapy. Food Chem Toxicol 49:2773–2779. doi: 10.1016/j.fct.2011.07.046
    Dosseh C, Morreti C, Tessier AM, Delaveau P (1980) Étude chimique des feuilles de Byrsonima verbascifolia rich. Ex Juss es Plantes Médicinales et Phytothérapie 14:136–142
    Espanha LG, Resende FA, Lima Neto JS, Boldrin PK, Nogueira CH, Santoro de Camargo M, De Grandis RA, Campaner dos Santos L, Vilegas W, Varanda EA (2014) Mutagenicity and antimutagenicity of six Brazilian Byrsonima species assessed by the Ames test. J Altern Complement Med 14:1–10. doi: 10.1186/1472-6882-14-182
    Guilhon-Simplicio F, Pereira MM (2011) Aspectos químicos e farmacológicos de Byrsonima (MALPIGHIACEAE). Quim Nova 34:1032–1041. doi: 10.1590/S0100-40422011000600021
    Han M, Li JF, Tan Q, Sun YY, Wang YY (2010) Limitations of the use of MTT assay for screening in drug discovery. J Chin Pharma Sci 9:195–200. http://118.145.16.238/Jwk_zgyxen/EN/Y2010/V19/I3/195
    Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316–323
    Kirkland D, Pfuhler S, Tweats D, Aardema M, Corvi R, Darroudi F, Elhajouji A, Glatt H, Hastwell P, Hayashi M, Kasper P, Kirchner S, Lynch S, Marzin D, Maurici D, Meunier JR, Müller L, Nohynek G, Parry J, Parry E, Thybaud V, Tice R, Benthem J, Vanparys P, White P (2007) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM workshop. Mutat Res 628:31–55. doi: 10.1016/j.mrgentox.2006.11.008
    Korzeniewski C, Callewaert DM (1983) An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64:313–320. doi: 10.1016/0022-1759(83)90438-6
    Lima ZP, Santos RC, Torres TU (2008) Byrsonima fagifolia: an integrative study to validate the gastroprotective, healing, antidiarrheal, antimicrobial and mutagenic action. J Ethnopharmacol 120:149–160. doi: 10.1016/j.jep.2008.07.047
    Maldini M, Sosa S, Montoro P, Giangaspero A, Balick MJ, Pizza C, Della Loggia R (2009) Screening of the topical antiinflammatory activity of the bark of Acacia cornigera Willdenow, Byrsonima crassifolia Kunth, Sweetia panamensis Yakovlev and the leaves of Sphagneticola trilobata Hitchcock. J Ethnopharmacol 122:430–433. doi: 10.1016/j.jep.2009.02.002
    Michelin DC, Sannomiya M, Figueiredo ME, Rinaldo D, Santos LC, Souza-Brito ARM, Vilegas W, Salgado HRN (2008) Antimicrobial activity of Byrsonima species (MALPIGHIACEAE). Rev Bras Farmacogn 18:690–695. doi: 10.1590/S0102-695X2008000500009
    Moreira LQ, Vilela FC, Orlandi L, Dias DF, Santos ALA, da Silva MA, Paiva R, Alves-da-Silva G, Giusti-Paiva A (2011) Anti-inflammatory effect of extract and fractions from the leaves of Byrsonima intermedia A. Juss. in rats. J Ethnopharmacol 138:610–615. doi: 10.1016/j.jep.2011.10.006
    Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival. J Immunol Methods 65:55–63. doi: 10.1016/0022-1759(83)90303-4
    Newman DJ, Cragg GM (2012) Natural Products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311–335. doi: 10.1021/np200906s
    OECD (2015) Guidance document on revisions to OECD genetic toxicology test guidelines. Genetic toxicology Guidance Document, 31 Aug
    Pereira VV, Borel CR, Silva RR (2015) Phytochemical screening, total phenolic content and antioxidant activity of Byrsonima species. Nat Prod Res. doi: 10.1080/14786419.2014.1002407
    Plumb JA, Milroy R, Kaye SB (1989) Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 49:4435–4440
    Rampersad SN (2012) Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors 12(9):12347–12360. doi: 10.3390/s120912347
    Rates SMK (2001) Plants as source of drugs. Toxicon 39:603–613. doi: 10.1016/S0041-0101(00)00154-9
    Repetto G, Del Peso A, Zurita JL (2008) Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 3:1125–1131. doi: 10.1038/nprot.2008.75
    Ribeiro DL, Cilião HL, Specian AFL, Serpeloni JM, Souza MF, Tangerina MMP, Vilegas W, Boldrin PK, Resende FA, Varanda EA, Vilegas W, Martínez-López W, Sannomiya M, Cólus IMS (2016) Chemical and biological characterisation of Machaerium hirtum (Vell.) Stellfeld: absence of cytotoxicity and mutagenicity and possible chemopreventive potential. Mutagenesis 31:146–160. doi: 10.1093/mutage/gev066
    Rinaldo D, Batista JM Jr, Rodrigues J, Benfatti AC, Rodrigues CM, Dos Santos LC, Furlan M, Vilegas W (2010) Determination of catechin diastereomers from the leaves of Byrsonima species using chiral HPLC-PAD-CD. Chirality 22:726–733. doi: 10.1002/chir.20824
    Sannomiya M, Fonseca VB, Silva MA, Rocha LRM, Dos Santos LC, Hiruma-Lima CA, Souza Brito ARM, Vilegas W (2005a) Flavonoids and antiulcerogenic activity from Byrsonima crassa leaves extracts. J Ethnopharmacol 97:1–6. doi: 10.1016/j.jep.2004.09.053
    Sannomiya M, Montoro P, Piacente S, Pizza C, Souza Brito ARM, Vilegas W (2005b) Application of liquid chromatography/electropsray ionization tandem mass spectrometry to the analysis of polyphenolic compounds from an infusion of Byrsonima crassa Niedenzu. Rapid Commun Mass Spectrom 19:2244–2250. doi: 10.1002/rcm.2053
    Sannomiya M, Silva MA, dos Santos LC, de Almeida LFR, Souza Brito ARM, Salgado HRN, Vilegas W (2005c) Avaliação química e da atividade antidiarréica das folhas de Byrsonima cinera DC. (Malpighiaceae). Braz J Pharm Sci 41:79–83. doi: 10.1590/S1516-93322005000100009
    Sannomiya M, dos Santos LC, Carbone V, Napolitano A, Piacente S, Pizza C, Souza-Brito ARM, Vilegas W (2007a) Liquid chromatography/electrospray ionization tandem mass spectrometry profiling of compounds from the infusion of Byrsonima fagifolia Niedenzu. Rapid Commun Mass Spectrom 21:1393–1400. doi: 10.1002/rcm.2971
    Sannomiya M, Cardoso CRP, Figueiredo ME, Rodrigues CM, Dos Santos LC, Dos Santos FV, Serpeloni JM, Cólus IMS, Vilegas W, Varanda EA (2007b) Mutagenic evaluation and chemical investigation of Byrsonima intermedia A. Juss. leaf extracts. J Ethnopharmacol 112:319–326. doi: 10.1016/j.jep.2007.03.014
    Santos RC, Kushima H, Rodrigues CM, Sannomiya M, Rocha LRM, Bauab TM, Tamashiro J, Vilegas W, Hiruma-Lima CA (2012) Byrsonima intermedia A. Juss.: gastric and duodenal anti-ulcer, antimicrobial and antidiarrheal effects in experimental rodent models. J Ethnopharmacol 140:203–212. doi: 10.1016/j.jep.2011.12.008
    Scudiero DA, Shoemaker RH, Paul KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827–4833
    Serpeloni JM, Specian AFL, Ribeiro DL, Tuttis K, Vilegas W, Martínez-López W, Dokkedal AL, Saldanha LL, Cólus IMS, Varanda EA (2015) Antimutagenicity and induction of antioxidant defense by flavonoid rich extract of Myrcia bella Cambess. in normal and tumor gastric cells. J Ethnopharmacol 176:345–355. doi: 10.1016/j.jep.2015.11.003
    SIGMA-ALDRICH (2012) Benzo[a]pyrene. http://www.sigmaaldrich.com/catalog/product/sigma/b1760?lang=pt®ion=BR . Accessed 2012
    Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107–1112. doi: 10.1093/jnci/82.13.1107
    Sumantran Venil N (2011) Cellular chemosensitivity assays: an overview. Cancer Cell Cult Methods Protoc 731:219–236
    Ulukaya E, Ozdikicioglu F, Oral AY, Demirci M (2008) The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested. Toxicol In Vitro 22:232–239. doi: 10.1016/j.tiv.2007.08.006
    Uno S, Dalton TP, Dragin N, Curran CP (2006) Oral Benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol Pharmacol 69:1103–1112. doi: 10.1124/mol.105.021501
    Van Tonder A, Joubert AM, Cromarty AD (2015) Limitations of the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. BMC Res Notes 8:1. doi: 10.1186/s13104-015-1000-8
    Wang S, Yu H, Wickliffe JK (2011) Limitation of the MTT and XTT assays for measuring cell viability due to superoxide formation induced by nano-scale TiO2. Toxicol In Vitro 25:2147–2151. doi: 10.1016/j.tiv.2011.07.007
    Weyermann J, Lochmann D, Zimmer A (2005) A practical note on the use of cytotoxicity assays. Int J Pharm 288:369–376. doi: 10.1016/j.ijpharm.2004.09.018
    Zhang Q, Zhao XH, Wang ZJ (2009) Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G 2/M arrest and apoptosis. Toxicol In Vitro 23:797–807. doi: 10.1016/j.tiv.2009.04.007